tiprankstipranks
Trending News
More News >
Stoke Therapeutics Inc (STOK)
NASDAQ:STOK
US Market

Stoke Therapeutics (STOK) Income Statement

Compare
465 Followers

Stoke Therapeutics Income Statement

Last quarter (Q3 2025), Stoke Therapeutics's total revenue was $10.63M, an increase of 117.25% from the same quarter last year. In Q3, Stoke Therapeutics's net income was $-38.35M. See Stoke Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 36.55M$ 8.78M$ 12.40M$ 0.00$ 0.00
Gross Profit
$ 36.55M$ 8.78M$ 12.40M$ 0.00$ -1.93M
Operating Expenses
$ 137.93M$ 123.55M$ 116.76M$ 86.06M$ 51.12M
Depreciation and Amortization
$ 2.18M$ 2.47M$ 1.55M$ 974.00K$ 1.93M
EBITDA
$ -99.19M$ -112.30M$ -102.81M$ -85.09M$ -50.32M
Operating Income
$ -101.37M$ -114.77M$ -104.36M$ -86.06M$ -53.04M
Other Income/Expenses
$ 12.39M$ 10.07M$ 3.29M$ 260.00K$ 801.00K
Pretax Income
$ -88.98M$ -104.70M$ -101.07M$ -85.81M$ -52.24M
Net Income
$ -88.98M$ -104.70M$ -101.07M$ -85.81M$ -52.24M
Per Share Metrics
Basic EPS
$ -1.65$ -2.38$ -2.60$ -2.34$ -1.56
Diluted EPS
$ -1.65$ -2.38$ -2.60$ -2.34$ -1.56
Weighted Average Shares Outstanding
54.01M 43.99M 38.90M 36.74M 33.49M
Weighted Average Shares Outstanding (Diluted)
54.01M 43.99M 38.90M 36.74M 33.49M
Currency in USD

Stoke Therapeutics Earnings and Revenue History